Use of ferric oxide for treating immune deficiency

摘要

The invention relates to the use of very finely divided ferrous (III) oxide (Fe2O3) and/or its hydroxide for the treatment of immune deficiencies, especially Acquired Immune Deficiency Syndrome (AIDS), or of immune deficiency caused by the Human Immunodeficiency Virus (HIV). This basic and active substance with its antiviral effect is non-tocic, its dosage is not critical and has no side-effects, and is preferably intended for use as an oral medicament after the establishment of an immunodeficient disease in humans and animals.